• Apr 24, 2025

West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars

Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 18.1% above analysts’ consensus estimates.

  • Apr 24, 2025

Analysts game out use of Fed toolkit if market needs central bank's help

NEW YORK (Reuters) -Market participants unsettled by the Trump administration's choppy policy rollout are working to game out what the Federal Reserve would do if asset prices spiral out of control and require stabilization by the U.S. central bank. The anxiety arises from weeks of volatile trading and big price declines across a range of securities due to President Donald Trump's seesawing tariffs announcements, which are widely expected to stoke inflation while depressing growth and hiring. A more recent wave of price swings followed on the heels of Trump's attacks on the Fed for not cutting interest rates since he returned to power in January and his public musings about firing Fed Chair Jerome Powell.

  • Apr 24, 2025

One of Wall Street’s biggest bulls slashes view as tariffs bite

(Bloomberg) -- One of Wall Street’s biggest bulls is throwing in the towel on expectations for large gains this year, seeing tariffs hitting corporate America the hardest.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisThe Racial Wealth Gap Is Not Just About MoneyTo Fuel Affordable Housing, This Innovation Fund Targets Predevelopment CostsDe

  • Apr 24, 2025

Wall Street stocks traders comb through charts for clues to next S&P 500 move

(Bloomberg) -- In recent days, the wild swings in US stocks, largely driven by President Donald Trump’s repeated U-turns on tariffs, have caused many on Wall Street to throw up their hands in exasperation.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisThe Racial Wealth Gap Is Not Just About MoneyTo Fuel Affordable Housing, This Innovation F

  • Apr 24, 2025

3 Reasons to Avoid MKFG and 1 Stock to Buy Instead

In a sliding market, Markforged has defied the odds, trading up to $4.80 per share. Its 6% gain since October 2024 has outpaced the S&P 500’s 8.1% drop. This performance may have investors wondering how to approach the situation.

  • Apr 24, 2025

3 Reasons to Sell WOR and 1 Stock to Buy Instead

In a sliding market, Worthington has defied the odds, trading up to $46.92 per share. Its 21.6% gain since October 2024 has outpaced the S&P 500’s 8.1% drop. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.